Open AccessEffect of an Electronic Medication Reconciliation Application and Process Redesign on Potential Adverse Drug Events
Author(s) -
Jeffrey L. Schnipper,
Claus Hamann,
Chima D. Ndumele,
Catherine L. Liang,
Marcy G. Carty,
Andrew S. Karson,
Ishir Bhan,
Christopher M. Coley,
Eric G. Poon,
Alexander Turchin,
Stephanie Labonville,
Ellen K. Diedrichsen,
Stuart R. Lipsitz,
Carol A. Broverman,
Patricia McCarthy,
Tejal K. Gandhi
Publication year - 2009
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinternmed.2009.51
Subject(s) - medicine , adverse effect , medication reconciliation , patient safety , emergency medicine , confidence interval , computerized physician order entry , intervention (counseling) , relative risk , medical emergency , harm , randomized controlled trial , medline , medical record , health care , family medicine , pharmacy , nursing , pharmacist , psychology , political science , law , economics , economic growth , social psychology
Medication reconciliation at transitions in care is a national patient safety goal, but its effects on important patient outcomes require further evaluation. We sought to measure the impact of an information technology-based medication reconciliation intervention on medication discrepancies with potential for harm (potential adverse drug events [PADEs]).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom